合計 50 件の最近のインサイダー取引記録が記録されています Compass Therapeutics, Inc. (CMPX), 内訳は 35 件の買い および 11 件の売り. インサイダー買い総額は $40.34M インサイダー売り総額は $12.64M.
最近活動のある主要インサイダーには Schuetz Thomas J., Lindahl Richard S, Gray Mary Ann. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CMPX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 源泉徴収 |
36,687 |
$6.52 |
$239.2K |
6,603,336 |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 源泉徴収 |
46,777 |
$5.35 |
$250.26K |
6,640,023 |
| 2026-01-02 |
Lindahl Richard S |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gray Mary Ann |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gordon Carl L |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Chiniara Ellen |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
RSU 付与（制限付株式） |
62,500 |
$5.17 |
$323.13K |
382,500 |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
RSU 付与（制限付株式） |
2,000,000 |
$5.17 |
$10.34M |
2,000,000 |
| 2026-01-02 |
Shin Barry |
CFO |
RSU 付与（制限付株式） |
125,000 |
$5.17 |
$646.25K |
525,000 |
| 2026-01-02 |
Sirard Cynthia |
Officer |
不明 |
- |
- |
- |
- |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
RSU 付与（制限付株式） |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2026-01-02 |
Ferneau Philip |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Boylan James P |
Director |
RSU 付与（制限付株式） |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
RSU 付与（制限付株式） |
150,000 |
$5.17 |
$775.5K |
171,000 |
| 2026-01-02 |
Prasad Arjun |
Officer |
不明 |
- |
- |
- |
- |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
RSU 付与（制限付株式） |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 源泉徴収 |
44,025 |
$4.83 |
$212.64K |
6,436,800 |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
情報に基づく買い |
10,000 |
$2.11 |
$21.1K |
6,480,825 |
| 2025-04-09 |
Orbimed Advisors Llc |
10 Percent Owner |
情報に基づく売り |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-09 |
Gordon Carl L |
10 Percent Owner |
情報に基づく売り |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-07 |
Lerner Neil |
Chief Accounting Officer |
情報に基づく買い |
20,000 |
$1.42 |
$28.4K |
320,000 |
| 2025-04-07 |
Anderman Jonathan |
Gen Counsel & Corporate Sec |
情報に基づく買い |
20,000 |
$1.54 |
$30.8K |
21,000 |
| 2025-02-11 |
Lindahl Richard S |
Director |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gray Mary Ann |
Director |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gordon Carl L |
10 Percent Owner |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Chiniara Ellen |
Director |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Lerner Neil |
SVP, CAO |
RSU 付与（制限付株式） |
200,000 |
$3.65 |
$730K |
200,000 |
| 2025-02-11 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,500,000 |
$3.65 |
$5.48M |
1,500,000 |
| 2025-02-11 |
Shin Barry |
CFO |
RSU 付与（制限付株式） |
250,000 |
$3.65 |
$912.5K |
250,000 |
| 2025-02-11 |
Ferneau Philip |
Director |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Boylan James P |
Director |
RSU 付与（制限付株式） |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
RSU 付与（制限付株式） |
280,000 |
$3.65 |
$1.02M |
280,000 |
| 2025-02-08 |
Schuetz Thomas J. |
CEO |
RSU 源泉徴収 |
41,687 |
$3.50 |
$145.9K |
6,470,825 |
| 2025-01-09 |
Schuetz Thomas J. |
CEO |
RSU 源泉徴収 |
58,054 |
$1.86 |
$107.98K |
6,512,512 |
| 2024-12-09 |
Lerner Neil |
VP Finance |
不明 |
175,000 |
$1.20 |
$210K |
- |
| 2024-12-09 |
Shin Barry |
Officer |
不明 |
- |
- |
- |
- |
| 2024-12-09 |
Shin Barry |
CFO |
RSU 付与（制限付株式） |
400,000 |
$1.65 |
$660K |
400,000 |
| 2024-08-13 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
RSU 付与（制限付株式） |
300,000 |
$1.20 |
$360K |
300,000 |
| 2024-08-01 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
処分 |
80,000 |
$1.57 |
$125.6K |
- |
| 2024-03-08 |
Boylan James P |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.96 |
$78.4K |
40,000 |
| 2024-02-09 |
Lindahl Richard S |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gray Mary Ann |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gordon Carl L |
10 Percent Owner |
RSU 付与（制限付株式） |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Chiniara Ellen |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Ferneau Philip |
Director |
RSU 付与（制限付株式） |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-08 |
Schuetz Thomas J. |
President |
RSU 源泉徴収 |
44,782 |
$1.45 |
$64.93K |
6,570,566 |
| 2024-02-08 |
Bisker-leib Vered |
Chief Executive Officer |
RSU 源泉徴収 |
49,198 |
$1.45 |
$71.34K |
3,124,426 |
| 2024-01-09 |
Schuetz Thomas J. |
President of R&d |
RSU 付与（制限付株式） |
637,500 |
$1.93 |
$1.23M |
637,500 |
| 2024-01-09 |
Bisker-leib Vered |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,753,125 |
$1.93 |
$3.38M |
1,753,125 |
| 2023-11-17 |
Schuetz Thomas J. |
Chief Executive Officer |
RSU 源泉徴収 |
44,025 |
$1.50 |
$66.04K |
5,977,848 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
